Last updated on April 20, 2014 at 8:28 EDT

Global Metabolomics Market Worth $1.5 Billion by 2017

January 11, 2013

DALLAS, January 11, 2013 /PRNewswire/ –

The report “Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite
Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and
Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017″, analyses the
global metabolomics market by region, applications and indications with five year revenue
forecasts. It also identifies the factors driving and restraining the global metabolomics
market with analysis of trends, opportunities and challenges.

The market is segmented and the revenue is forecasted on the basis of major regions
such as America, Europe, Asia and Rest of the World (ROW) covering the key countries for
each region. Further, the market is also segmented and revenues are forecasted on the
basis of applications and disease indications.

Browse 11 market data tables and 36 figures spread through136 slidesand in-depth TOC
on “Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By
Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications
(Oncology/Cardiology/Neurology) -Forecasts from 2012 to 2017″


Early buyers will receive 10% customization on reports.

In the post genomic era, metabolomics is gaining importance as another promising
“omic” technology for understanding the biology of various diseases. Rapid advancement has
been occurring in prediction, detection, monitoring and understanding of various diseases
using metabolomic technologies.

The market for metabolomic data analysis tools and software is increasing at a higher
rate. Metabolomics allows pharma companies to stretch their R&D efforts by improving
efficiency in target discovery and validation, mode-of-action, and toxicology studies.
There has been a significant global growth in biotechnology and pharmaceutical industries
in the last decade and the market is expected to have a double-digit growth rate in the
coming years.

Biomarker discovery services and increased need for toxicity testing are driving the
metabolomics market
[http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html ].
Nutraceuticals, plant genomics, nutri-genomics, and systems biology are some high growth
and emerging application areas that are expected to drive the global market of
metabolomics in coming years. The global market for metabolomics in terms of revenue is
estimated to be worth $343 million in 2012 and is expected to reach $1.5 billion by 2017,
growing at a CAGR of 35% from 2012 to 2017.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. M&M covers thirteen industry verticals, including advanced
materials, automotives and transportation, banking and financial services, biotechnology,
chemicals, consumer goods, energy and power, food and beverages, industrial automation,
medical devices [
http://www.marketsandmarkets.com/medical-device-market-research-11.html ],
pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository. To know more about us and
our reports, please visit our website http://www.marketsandmarkets.com

        Mr. Rohan
        North - Dominion Plaza,
        17304 Preston Road,
        Suite 800, Dallas, TX 75252
        Tel: +1-888-6006-441
        Email: sales@marketsandmarkets.com
        MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com




SOURCE MarketsandMarkets

Source: PR Newswire